Jung Yeon Lim

Comparative analysis of the safety and efficacy of 3D-bioprinted constructs embedded with human mesenchymal stem cells for bone regeneration

Jung Ho Jeon, Jae-Seok Kim, Hun‐Jin Jeong, Eun Chae Kim et autres

Intranasal Administration of Human Neural Crest-Derived Nasal Turbinate Stem Cells Attenuates Microglia Activity in Mild Head Trauma Models

Jung Eun Lee, Jung Yeon Lim, Su Jeong Song, Sun Hwa Park et autres

kr, us, gb (code pays fourni par la source)

Human nasal turbinate stem cells with specific gene signatures (HAS2, CXCL1, KRTAP1-5, GSTT2B, and C4B) attenuate rheumatoid arthritis

Jaeseon Lee, Hong Ki Min, Jung Yeon Lim, Young-Suk Song et autres

This study aimed to investigate the therapeutic effect of human nasal turbinate-derived stem cells (hNTSCs) on mice with rheumatoid arthritis (RA) and identify hNTSC gene signatures with therapeutic effects on RA. hNTSCs were obtained from 20 healthy controls (HCs) who had undergone …

kr, gb, us (code pays fourni par la source)

Data from Effective Combination Therapy for Malignant Glioma with TRAIL-Secreting Mesenchymal Stem Cells and Lipoxygenase Inhibitor MK886

Seong Muk Kim, Ji Sun Woo, Chang Hyun Jeong, Chung Heon Ryu et autres

Abstract The apoptotic ligand TRAIL is believed to have promise as a cancer gene therapy, yet many types of cancer, including gliomas, have exhibited resistance to TRAIL-induced apoptosis. Here, we show that therapeutic combination of the lipoxygenase inhibitor MK886 and TRAIL-secreting human …

Supplementary Figure 1 from Effective Combination Therapy for Malignant Glioma with TRAIL-Secreting Mesenchymal Stem Cells and Lipoxygenase Inhibitor MK886

Seong Muk Kim, Ji Sun Woo, Chang Hyun Jeong, Chung Heon Ryu et autres

PDF file - 2.1MB, Cytotoxic effect of the treatment with AA861 on glioma cell death

Supplementary Figure 3 from Effective Combination Therapy for Malignant Glioma with TRAIL-Secreting Mesenchymal Stem Cells and Lipoxygenase Inhibitor MK886

Seong Muk Kim, Ji Sun Woo, Chang Hyun Jeong, Chung Heon Ryu et autres

PDF file - 2.6MB, DR5-mediated cytotoxic effect of combined treatment with AA861 and TRAIL

Supplementary Figure Legends 1-3 from Effective Combination Therapy for Malignant Glioma with TRAIL-Secreting Mesenchymal Stem Cells and Lipoxygenase Inhibitor MK886

Seong Muk Kim, Ji Sun Woo, Chang Hyun Jeong, Chung Heon Ryu et autres

PDF file - 72K

Supplementary Figure 2 from Effective Combination Therapy for Malignant Glioma with TRAIL-Secreting Mesenchymal Stem Cells and Lipoxygenase Inhibitor MK886

Seong Muk Kim, Ji Sun Woo, Chang Hyun Jeong, Chung Heon Ryu et autres

PDF file - 1.8MB, Upregulation of DR5 after treatment with MK886 in glioma cells

Supplementary Figure 3 from Effective Combination Therapy for Malignant Glioma with TRAIL-Secreting Mesenchymal Stem Cells and Lipoxygenase Inhibitor MK886

Seong Muk Kim, Ji Sun Woo, Chang Hyun Jeong, Chung Heon Ryu et autres

PDF file - 2.6MB, DR5-mediated cytotoxic effect of combined treatment with AA861 and TRAIL

Supplementary Figure 2 from Effective Combination Therapy for Malignant Glioma with TRAIL-Secreting Mesenchymal Stem Cells and Lipoxygenase Inhibitor MK886

Seong Muk Kim, Ji Sun Woo, Chang Hyun Jeong, Chung Heon Ryu et autres

PDF file - 1.8MB, Upregulation of DR5 after treatment with MK886 in glioma cells

Supplementary Figure 1 from Effective Combination Therapy for Malignant Glioma with TRAIL-Secreting Mesenchymal Stem Cells and Lipoxygenase Inhibitor MK886

Seong Muk Kim, Ji Sun Woo, Chang Hyun Jeong, Chung Heon Ryu et autres

PDF file - 2.1MB, Cytotoxic effect of the treatment with AA861 on glioma cell death

Supplementary Figure Legends 1-3 from Effective Combination Therapy for Malignant Glioma with TRAIL-Secreting Mesenchymal Stem Cells and Lipoxygenase Inhibitor MK886

Seong Muk Kim, Ji Sun Woo, Chang Hyun Jeong, Chung Heon Ryu et autres

PDF file - 72K